Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)
Background: Immune checkpoint inhibitor (ICI)-based combination therapy modalities for hepatocellular carcinoma (HCC) have achieved significant efficacy in clinical research and practice and have become the mainstay for the treatment of unresectable HCC. Summary: To better help clinicians use combin...
Main Authors: | Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-01-01
|
Series: | Liver Cancer |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/535496 |
Similar Items
-
Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)
by: The Society of Gynecological Cancer of China Anti-Cancer Association
Published: (2022-08-01) -
Interpretation of Expert Consensus on Diagnosis and Treatment of Cutaneous Basal Cell Carcinoma (2021) by A Multidisciplinary Team
by: WANG Hongbing, et al.
Published: (2023-04-01) -
The protocol for the consensuses of Chinese experts on glioma multidisciplinary team management
by: The National Glioma MDT Alliance National Center for Neurological Disorders, et al.
Published: (2022-01-01) -
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
by: Wenxian Wang, et al.
Published: (2022-12-01) -
Expert consensus on genetic counseling in gynecological oncology (2023 edition)
Published: (2023-11-01)